Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07221279 · ClinicalTrials.gov registry record · NA

Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults

A NA study of Hypertension and Dyslipidemia, sponsored by Kennesaw State University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT07221279 is a NA study of Hypertension and Dyslipidemia that is actively recruiting participants, run by Kennesaw State University. The registered enrollment target is 200 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07221279, a NA study of Hypertension and Dyslipidemia, is actively recruiting participants, sponsored by Kennesaw State University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The prevalence of overweight and obesity remains epidemic in the United States, with some of the highest rates seen in older adults. While this phenomenon is certainly multifactorial, a good deal of evidence suggests that insufficient physical activity (PA) contributes significantly. Pilot data recently collected in a laboratory indicates a strong, inverse relationship between daily step counts and body fatness and cardiometabolic risk (CMR) factors when step counts are expressed relative to fat mass in young adults. This expression of PA may be especially predictive of body composition because it is influenced by factors that influence appetite and energy intake, energy expenditure, and the energy "reservoir" that is represented by body fat stores, all three elements of the "settling point" model of body weight. The strength of this relationship suggests that prescription of step counts that consider current body weight and composition, and weight loss goal, may yield predictable changes in weight and CMR in adults eating ad libitum. The long-term objective of this study is to quantify the relationship between daily step counts and body composition in young, middle aged, and older adults who are overweight/obese and develop a regression model that can be used to prescribe physical activity (daily step counts) for achieving a specific target body weight and predictably improving CMR risk for young, middle-aged, and older adult men and women over eight months while eating ad libitum. To achieve this objective, investigators will undertake two specific aims: 1) quantify the relationship between average steps·kg fat mass-1·day-1 and body composition/CMR profiles in healthy, overweight, and obese adults 20-39 years, 40-59 years, 60-79 years, and 80-plus years old, using inexpensive, widely available triaxial pedometers while eating ad libitum, and 2) quantify the efficacy of employing targeted step counts expressed as steps·kg fat mass-1·day-1 using the model developed

Interventions

  • BEHAVIORAL Step counts for predictable changes in body weight/compositon and cardiometabolic risk

Study Locations (1)

Georgia

  • Kennesaw State Universityh - Kennesaw

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-01-13
Est. Completion 2027-08-31
Phase NA

Sponsor

Kennesaw State University

8 total trials

What the Registry Record Tells You About NCT07221279

The ClinicalTrials.gov registry entry for NCT07221279 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The listed sponsor is Kennesaw State University, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Step counts for predictable changes in body weight/compositon and cardiometabolic risk is the first listed.

NCT07221279 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT07221279 about?

NCT07221279 is a clinical study titled "Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults". The prevalence of overweight and obesity remains epidemic in the United States, with some of the highest rates seen in older adults. While this phenomenon is certainly multifactorial, a good deal of evidence suggests that insufficient physical activity (PA) contributes significantly. Pilot data rece...

What is the current status of trial NCT07221279?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-01-13. Estimated completion is 2027-08-31.

What conditions does trial NCT07221279 study?

This clinical trial studies the following conditions: Hypertension, Dyslipidemia, Obesity & Overweight, Insulin Resistance Syndrome, Inflammation Chronic.

What interventions are being tested in trial NCT07221279?

The interventions under investigation include: Step counts for predictable changes in body weight/compositon and cardiometabolic risk (BEHAVIORAL).

Who is sponsoring clinical trial NCT07221279?

This trial is sponsored by Kennesaw State University, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07221279 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.